03.01.13
Biova LLC, developers of patented Hydro5 technology for water-soluble egg membrane, has increased the standardized protein profile of its BiovaFlex ingredient to what they believe is a market-leading 88%. Introduced in 2009, BiovaFlex water soluble egg membrane is made in the U.S. at their Iowa State University Research Park facility. Featuring a nutrient rich, uniform ingredient profile, BiovaFlex is used in joint health applications around the world.
“The science indicates bioactivity is tied to the natural, non-denatured egg membrane matrix,” said Matt Stegenga, Biova director of marketing. “The primary composition of this matrix is a natural ratio of complex proteins including glycosaminoglycans, collagen, elastin, desmosine, isodesmosine and transforming growth factor. So yes, hitting uniform 88% protein across all BiovaFlex production is significant for us because it’s important for our customers’ products.”
For further information: www.biova.com
“The science indicates bioactivity is tied to the natural, non-denatured egg membrane matrix,” said Matt Stegenga, Biova director of marketing. “The primary composition of this matrix is a natural ratio of complex proteins including glycosaminoglycans, collagen, elastin, desmosine, isodesmosine and transforming growth factor. So yes, hitting uniform 88% protein across all BiovaFlex production is significant for us because it’s important for our customers’ products.”
For further information: www.biova.com
